Skip to Main Content

Paper Details

Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Acta Neuropathol
5
2023
ATRX, CDKN2A/B, CNS, CNS neoplasms, CNS tumor, DNA methylation, GTAKA, Glioneuronal, Glioneuronal tumor, Glioneuronal tumors, NTRK, NTRK gene, NTRK gene fusions, NTRK1-3, RTK, RTK fusions, brain tumor, gene fusions, glioneuronal, glioneuronal tumor, glioneuronal tumors, patients, receptor tyrosine-kinases, tumors, tyrosine
Author NameAffiliation
Martin SillHopp Children's Cancer Center Heidelberg (KiTZ)
Martin SillGerman Cancer Research Center (DKFZ)
Till MildeHopp Children's Cancer Center Heidelberg (KiTZ)
Till MildeClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ)
Till MildeUniversity Hospital Heidelberg
Till MildeNational Center for Tumor Diseases (NCT)
Kristian W PajtlerHopp Children's Cancer Center Heidelberg (KiTZ)
Kristian W PajtlerUniversity Hospital Heidelberg
Kristian W PajtlerGerman Cancer Research Center (DKFZ)
Kristian W PajtlerHopp Children's Cancer Center Heidelberg (KiTZ)
Kristian W PajtlerGerman Cancer Research Center (DKFZ)
Kristian W PajtlerUniversity Hospital Heidelberg
Stephan FrankInstitute for Pathology, University Hospital Basel
Daniel R Bou??Nationwide Children's Hospital and the Ohio State University
Daniel R Bou??Nationwide Children's Hospital and the Ohio State University
Zied AbdullaevCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Laveniya SatgunaseelanRoyal Prince Alfred Hospital
Ho-Keung NgThe Chinese University of Hong Kong
Ho-Keung Ng
Ho-Keung NgThe Chinese University of Hong Kong
Ho-Keung Ng
Christine HaberlerMedical University of Vienna
Pascale VarletSainte-Anne Hospital
Pascale VarletInstitut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM
Pascale VarletSainte-Anne Hospital
Pascale VarletInstitut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM
Sebastian BrandnerNational Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust
Sebastian BrandnerUCL Queen Square Institute of Neurology
Sanda AlexandrescuBoston Children's Hospital
Kenneth AldapeCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Kenneth AldapeCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Andrey KorshunovInstitute of Pathology, University Hospital Heidelberg
Andrey KorshunovHopp Children's Cancer Center Heidelberg (KiTZ)
Andrey KorshunovClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Andrey KorshunovInstitute of Pathology, University Hospital Heidelberg
Andrey KorshunovClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Andrey KorshunovHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittNational Center for Tumor Diseases (NCT)
Olaf WittUniversity Hospital Heidelberg
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ)
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ)
Olaf WittUniversity Hospital Heidelberg
Olaf WittNational Center for Tumor Diseases (NCT)
Christel Herold-MendeUniversity Hospital Heidelberg
Andreas UnterbergUniversity Hospital of Heidelberg
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterNational Center for Tumor Diseases (NCT)
Stefan M PfisterUniversity Hospital Heidelberg
  • 1 - 50

Datasets